Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |